Strides Pharma Science LtdNSE: STAR

Press Release Jun 24 2022

· Issued by Strides Pharma Science Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-24-2022-5

Strides Pharma Science Limited has informed the Exchange about press release dated 24-Jun-2022 titled Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

View Attachment

6ix hasn’t read this filing yet.

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases